Guidelines for the Pharmacological Management of Overactive Bladder Disease in Adults in Primary Care October 2020

  • Version
  • Download 82
  • File Size 1.03 MB
  • File Count 1
  • Create Date November 4, 2020
  • Last Updated November 4, 2020

Guidelines for the Pharmacological Management of Overactive Bladder Disease in Adults in Primary Care October 2020

Overactive Bladder (OAB)

Mirabegron

NICE TA290

Betmiga

Regurin

Vesicare

Detrunorm

Detrusitol

Lyrinel

Toviaz

Fesoteradine

Ditropan

Tolterodine

Oxybutynin

Oxybutynin MR

Trospium

Solifenacin

Mirabegron

Attached Files

FileAction
1604495750wpdm_OAB guidance updated October 2020 v1docx.pdfDownload